loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Dexlansoprazole

Menu
$ API Ref.Price (USD/KG) : 467Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 40TAKEDA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-951

Delist Requested :

Patent Use Description : TREATMENT OF HEARTBURN...

Patent Expiration Date : 2030-03-17

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-949

Delist Requested :

Patent Use Description : HEALING OF ALL GRADES ...

Patent Expiration Date : 2030-03-17

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-951

Delist Requested :

Patent Use Description : TREATMENT OF HEARTBURN...

Patent Expiration Date : 2030-03-17

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-950

Delist Requested :

Patent Use Description : MAINTAIN HEALING OF ER...

Patent Expiration Date : 2030-03-17

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-949

Delist Requested :

Patent Use Description : HEALING OF ALL GRADES ...

Patent Expiration Date : 2030-03-17

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 9233103

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-1805

Delist Requested :

Patent Use Description : USE OF DEXLANSOPRAZOLE...

Patent Expiration Date : 2032-03-05

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 9233103

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-1805

Delist Requested :

Patent Use Description : USE OF DEXLANSOPRAZOLE...

Patent Expiration Date : 2032-03-05

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 8173158

Drug Substance Claim :

Drug Product Claim :

Application Number : 22287

Patent Use Code : U-950

Delist Requested :

Patent Use Description : MAINTAIN HEALING OF ER...

Patent Expiration Date : 2030-03-17

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 9011926

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22287

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-24

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DEXLANSOPRAZOLE

US Patent Number : 7790755

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22287

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-02

blank